The global fetal bovine serum (FBS) market is witnessing steady growth due to increasing utilization of high-quality cell culture supplements in biotechnology, pharmaceutical research, vaccine manufacturing, regenerative medicine, and academic research. Fetal bovine serum provides essential nutrients, growth factors, hormones, and proteins required for optimal cell growth and proliferation in laboratory environments. Rising investments in drug discovery, stem cell research, biologics production, and precision medicine are further supporting market expansion. The market is projected to register a CAGR of 7.2% during the forecast period.
Red biotechnology refers to the application of biotechnological techniques to medical and health-care products and processes. It involves the use of organisms, or their cellular and molecular components, to develop drugs, diagnostics, and genetically modified organisms for therapeutic uses. The sector primarily focuses on the development of vaccines, antibiotics, regenerative therapies, genetic testing, and development of new drug therapies using genetic engineering and molecular biology techniques. The red biotechnology market is projected to grow at a compound annual growth rate (CAGR) of 5.7% over the forecast period.
The cell culture media, sera, and reagents market encompasses a range of products used in the growth, maintenance, and study of cells in vitro. Cell culture media are nutrient-rich solutions designed to support the growth and survival of cells in a laboratory environment. These media can be classified into several types, including serum-free, chemically defined, and protein-free varieties, depending on the specific requirements of the cell type being cultured. Sera, such as fetal bovine serum (FBS), provide a rich source of growth factors and hormones necessary for cell proliferation. Reagents, including supplements and growth factors, are added to the media to aid in cell metabolism, growth regulation, and morphological maintenance. The cell culture media, sera, and reagents market is projected to grow at a compound annual growth rate (CAGR) of 10.5% over the forecast period.
The vinyl sulfone market is expected to grow at a CAGR of 3.5% during the forecast period of 2025 to 2033, driven by key factors reshaping the industry landscape. The industry's growth is propelled by the expanding applications of divinyl sulfone, phenyl vinyl sulfone, and methyl vinyl sulfone, with each type playing a pivotal role at different points in time. The challenges in vinyl sulfone Ester adoption underscore the need for targeted strategies to unlock its full potential.
The metagenomics analysis market highlighting rampant growth at a compounded annual growth rate of 16.9% during the forecast period from 2025 to 2033. Increasing demand for microbial screening in food and chemical industry and significant increase in the bioinformatics segment drive the metagenomic analysis market growth.
The coenzyme A market will showcase impressive growth at a compounded annual growth rate (CAGR) of 8.1% during the forecast period from 2021 to 2029. Coenzyme A is an important biomolecule which has prominent significance in the enzymatic acyl group transfer reactions pertaining to oxidation and synthesis of fatty acids.
The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO), by 2020 chronic diseases will be responsible for 73% of the total global deaths associated with obesity, diabetes, cardiovascular complications and cancer.
The global orthobiologics market to reach US$ 9.6 billion in 2029 and projected to exhibit a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2021 to 2029. Orthobiologics are cellular therapy and biologics used to treat or manage certain orthopedic disorders.
Molecular weight markers are commonly known as DNA ladders, RNA ladders or protein ladders. The main function of the molecular weight markers is used for determination and identification of the molecular size of biological samples on gel electrophoresis by using the principle that molecular weight is inversely proportional to migration rate through a gel matrix.
Over the past 100 years cell culture has undergone tremendous evolution from laboratory curiosity into a valuable and widely used research and bio production tool. Earlier researchers used to employ hanging drop cultures or on the bottom of pyrex glass flask and petridishes, which were later replaced with collagen coated plates to improve cell attachment and growth.
The biotechnology market covers the use of biological systems, living organisms and cellular processes to develop products and technologies for healthcare, agriculture, food production, industrial processing and environmental management. Major areas include biopharmaceuticals, genomics, proteomics, bioinformatics, DNA sequencing, cell and gene therapy, tissue engineering, agricultural biotechnology, industrial biotechnology and bioprocessing.
The global biotechnology market is projected to increase from approximately USD 2.02 trillion in 2026 to USD 6.34 trillion by 2035, registering a CAGR of 13.61% during the forecast period. Market estimates may differ between research providers because biotechnology can be defined broadly or limited to selected products, technologies and applications.
Healthcare remains a major application area due to rising demand for biologic medicines, vaccines, diagnostic tests and personalized treatment. The growing prevalence of cancer, diabetes, autoimmune diseases and genetic disorders is supporting investment in new therapies. Cell and gene therapies are receiving increased attention because they can target the underlying causes of certain diseases. Biosimilars are also creating opportunities by improving access to biological medicines at potentially lower treatment costs.
Important market trends include the use of artificial intelligence in drug discovery, wider adoption of next-generation sequencing and increasing application of automation in laboratories and biomanufacturing facilities. AI-based platforms help researchers identify drug candidates, analyze biological data and improve clinical trial design. Advances in gene editing, synthetic biology and tissue engineering are supporting the development of new treatments, agricultural products and bio-based materials.
Agricultural biotechnology is growing as governments and producers look for ways to increase crop yield, improve resistance to pests and diseases, and reduce the use of chemical inputs. Industrial biotechnology is benefiting from demand for biofuels, enzymes, biodegradable materials and lower-emission manufacturing methods. These applications are expanding biotechnology beyond healthcare and creating additional commercial opportunities.
However, high research costs, lengthy clinical development, uncertain trial results and strict regulatory requirements can limit market growth. Biotechnology companies also face challenges related to intellectual property protection, patient-data security, manufacturing scale-up and access to specialized talent. Public concerns about genetic modification and gene editing may affect the adoption of certain products.
North America leads the market due to its established biopharmaceutical industry, research institutions, funding environment and clinical development capabilities. Europe maintains a strong position in pharmaceutical research and industrial biotechnology. Asia-Pacific is expected to record fast growth through 2035, supported by expanding healthcare demand, government investment, contract research and biomanufacturing capacity in China, India, Japan and South Korea.
Acute Market Reports provides biotechnology market research covering market size, technology assessment, application analysis, competitive landscape, regulatory conditions, regional opportunities and forecasts through 2035. These reports support biotechnology companies, pharmaceutical manufacturers, investors, research organizations and other decision-makers in evaluating market opportunities.